Global medical aesthetic medical device company Classis Co., Ltd. announced on the 9th that it held the 'Classis APAC Symposium 2025' in Bangkok, Thailand and participated in the IMCAS Asia 2025 (International Master Course on Aging Science Asia) held during the same period.
About 300 medical professionals and hospital/clinic staff from the Asia-Pacific region attended the symposium held at the Park Hyatt Hotel in Bangkok on June 6. Classis introduced various clinical experiences and treatment protocols centered on the Shrink Universe (overseas name: Ultraformer MPT) and Volnumer, which have sold over 18,000 units in the global market. Medical professionals from various countries including Korea, Indonesia, Japan, Thailand, and Australia participated as lecturers and shared the functions and clinical effects of the Shrink Universe and Volnumer, and emphasized the clinical synergy effect of the 'Volformer' combination treatment that combines the two devices.
Meanwhile, Klassis participated in IMCAS Asia 2025 held at the Athens Hotel in Bangkok from June 6 to 8, exhibiting major EBD equipment such as Shrink Universe, Volnumer, Reepot, and Curas Hybrid. In particular, the Industrial Symposium held on the 6th drew attention by sharing the technological differentiation of Reepot and Curas Hybrid and the latest clinical cases. In addition, the new product Quadessy, scheduled for domestic release in July, was introduced, drawing great attention on-site.
A Classys official said, “The Asian market is a key region for our global growth strategy, and we are maintaining solid growth by expanding new products and securing loyal customers in major countries such as Thailand and Japan.” He added, “We will further solidify our position in the global market by strengthening academic-centered marketing that reflects the characteristics of each country’s market and customer needs.”
- See more related articles
You must be logged in to post a comment.